Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 5, 2009, Pages 388-394

  Ting, Liang ^a   Tan, Tan ^a   Xiao, Yanhua ^a   Yi, Hong ^a   Li, Cui ^a   Peng, Fang ^a   Chen, Zhuchu ^a   Xiao, Zhiqiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Expression; Glioma pathogenesis related protein 1; Methylation

Indexed keywords

GLIPR1 PROTEIN, HUMAN; MESSENGER RNA; NERVE PROTEIN; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; DNA METHYLATION; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROMOTER REGION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; YOUNG ADULT;

EID: 67949095556     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Baylin S B. DNA methylation and gene silencing in cancer [J]. Nat Clin Pract Oncol, 2005, 2 (SI) : 4-11.
2. Merlo A, Herman J G, Mao L, et al. 5 ' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSl in human cancers [J]. Nat Med, 1995, 1(7) : 686-692.
3. Hsu H S, Wen C K, Tang Y A, et al. Promoter hyperm-ethylation is the predominant mechanism in hMLHl and hM-SH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer [J] . Clin Cancer Res, 2005, 11(15): 5410-5416.
4. Schildhaus H U, Krockel I, Lippert H, et al. Promoter hy-permethylation of p16INK4a, E-cadherin, 06-MGMT, DΛPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach [J] . Int J Oncol, 2005, 26(6) : 1493-1500.
5. Esteller M. DNA methylation and cancer therapy : new developments and expectations [J] . Curr Opin Oncol, 2005, 17(1) : 55-60.
6. Plimack E R, Kantarjian H M, Issa J P. Decitabine and its role in the treatment of hematopoietic malignancies [J] . Leukemia Lymphoma, 2007, 48(8): 1472-1481.
7. Murphy E V, Zhang Y, Zhu W, et al. The human glioma pathogenesis - related protein is structurally related to plant pathogenesis - related proteins and its gene is expressed specifically in brain tumors [J] . Gene, 1995, 159(1) :131-135.
8. Rich T, Chen P, Furman F, et al. RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin [J]. Gene, 1996, 180 ( 1 -2 ) : 125-130.
9. Rosenzweig T, Ziv-Av A, Xiang C, et al. Related to testes-specific, vespid, and pathogenesis protein -1 ( RTVP -1 ) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells [J] . Cancer Res, 2006, 66 (8) : 4139-4148.
10. Ren C, Li L, Goltsov A A, et al. mRTVP-1, a novel p53 target gene with proapoptotic activities [J] . Mol Cell Biol, 2002, 22(10) : 3345-3357.
11. Satoh T, Timme T L, Saika T, et al. Adenoviral vector -mediated mRTVP-1 gene therapy for prostate cancer [J] . Hum Gene Ther, 2003, 14(2) : 91-101.
12. Naruishi K, Timme T L, Kusaka N, et al. Adenoviral vector-mediated RTVP-1 gene - modified tumor cell-based vaccine suppresses the development of experimental prostate cancer [J]. Cancer Gene Ther, 2006, 13(7) :658-663.
13. Li, L, Abdel Fattah E, Cao G, et al. Glioma pathogenesis -related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling [J]. Cancer Res, 2008, 68(2) :434-443.
14. Ren C, Li L, Yang G, et al. RTVP -1, a tumor suppressor inactivated by methylation in prostate cancer [J] . Cancer Res, 2004, 64(3) : 969-976.
15. Gingras M C, Margolin J F. Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive sub-tractive hybridization [J]. Exp Hematol, 2000, 28 ( 1 ) : 65-76.